Chugai Pharmaceutical Co. Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
559.81 M |
Public Float |
- |
Chugai Pharmaceutical Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY181.81 |
Market Cap |
JPY4.05 T |
Shares Outstanding |
559.69 M |
Public Float |
205.55 M |
Address |
Nihonbashi Mitsui Tower, 15/F Tokyo Tokyo 103 Japan |
Employees | - |
Website | http://www.chugai-pharm.co.jp |
Updated | 07/08/2019 |
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. |